Related Experiment Video
Updated: Jun 13, 2026

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
Published on: February 10, 2023
The pathogenic m.3243A>T mitochondrial DNA mutation is associated with a variable neurological phenotype
Charlotte L Alston1, Andreas Bender, Iain P Hargreaves
1Institute for Ageing and Health, The Medical School, Newcastle University, Newcastle upon Tyne, UK.
The m.3243A>T mutation in mitochondrial DNA can cause rare mitochondrial diseases. This study investigates two new cases, revealing chronic progressive external ophthalmoplegia or hearing loss linked to COX deficiency.
Area of Science:
- Genetics
- Mitochondrial Biology
- Neurology
Background:
- The m.3243A>G mutation in the mitochondrial tRNA(Leu(UUR)) (MTTL1) gene is a known cause of mitochondrial DNA disease.
- The m.3243A>T transversion at the same site is less common but has been linked to encephalopathy and lactic acidosis.
Observation:
- This study reports on two additional patients with the m.3243A>T mutation.
- One patient presented with chronic progressive external ophthalmoplegia (CPEO).
- The other patient exhibited sensorineural hearing loss.
Findings:
- Single fiber mutation studies confirmed the segregation of the m.3243A>T mutation.
- The mutation was associated with cytochrome c oxidase (COX) deficiency.
Implications:
- These findings expand the known clinical spectrum associated with the m.3243A>T mitochondrial DNA mutation.
- This highlights the importance of genetic investigation for diverse neurological and ophthalmological presentations.
- Further research may clarify the pathogenic mechanisms and therapeutic strategies for m.3243A>T-related disorders.
More Related Videos
08:56Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Animal Mitochondrial Genetics
Mutations
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Huntington Disease l: Introduction
Malaria